The association between computed tomography attenuation value of renal angiomyolipoma associated with tuberous sclerosis complex and response to everolimus-Reference-Cited by-同舟云学术

The association between computed tomography attenuation value of renal angiomyolipoma associated with tuberous sclerosis complex and response to everolimus

Published:2024-01-06 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Liao Zhangcheng,Li Jiao,Zhao Yang,Wang Zhan,Wang Xu,Qiu Dongxu,Zhang Yushi^ORCID

Funder

National High Level Hospital Clinical Research Funding

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-023-04708-1.pdf

Reference24 articles.

1. Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372(9639):657–668

2. Hallett L, Foster T, Liu Z et al (2011) Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 27(8):1571–1583

3. Northrup H, Aronow ME, Bebin EM et al (2021) Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol 123:50–66

4. Franz DN, Bissler JJ, McCormack FX (2010) Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 41(5):199–208

5. Cai Y, Li H, Zhang Y (2017) Assessment of tuberous sclerosis complex associated with renal lesions by targeted next-generation sequencing in Mainland China. Urology 101:170e.171-170.e177

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patients;Heliyon;2024-08